Type |
Details |
Score |
Genotype |
Symbol: |
Egr2/Egr2 |
Background: |
B6.Cg-Egr2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
DO Term |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:5436064 |
Assay Type: |
RNA in situ |
Annotation Date: |
2012-09-26 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:3282012 |
Pattern: |
Regionally restricted |
Stage: |
TS12 |
Assay Id: |
MGI:5436256 |
Age: |
embryonic day 8.0 |
Image: |
1H |
Note: |
The stripes of expression in prospective rhombomeres 3 and 5 broadened and formed sharp boundaries. The domains coincided with Egr2 (Krox-20 lacZ staining). Expression was downregulated in rhombomere 4, but persisted at low level in 2 and dorsally in 6. |
Specimen Label: |
1H |
Detected: |
true |
Specimen Num: |
9 |
|
•
•
•
•
•
|
GXD Expression |
Probe: |
MGI:17719 |
Assay Type: |
RNA in situ |
Annotation Date: |
1999-05-06 |
Strength: |
Present |
Sex: |
Not Specified |
Emaps: |
EMAPS:1608911 |
Pattern: |
Regionally restricted |
Stage: |
TS11 |
Assay Id: |
MGI:1335751 |
Age: |
embryonic day 7.75 |
Image: |
2.B |
Note: |
A broad domain of expression is seen in the hindbrain. Higher levels of expression are coincident with the domain of Egr2 (Krox20) expression; lower levels extend to a boundary in the posterior hindbrain. |
Specimen Label: |
2.B |
Detected: |
true |
Specimen Num: |
2 |
|
•
•
•
•
•
|
Allele |
Name: |
regulatory region 102; targeted mutation 1.1, Mouse Clinical Institute |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Modified regulatory region |
|
•
•
•
•
•
|
Allele |
Name: |
regulatory region 102; targeted mutation 1.2, Mouse Clinical Institute |
Allele Type: |
Targeted |
Attribute String: |
Modified regulatory region |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
Wilm's tumour (WT) is an embryonal malignancy of the kidney, affecting around 1 in 10,000 infants. It occurs in both sporadic and hereditary forms. Inactivation of WT1 is one of the causes of Wilm's tumour. Defects in the WT1 gene are also associated with Denys-Drash Syndrome (DDS), which is characterised by typical nephropathy and genital abnormalities. The WT1 gene product shows similarity to the zinc fingers of the mammalian growth regulated EGR1 and EGR2 proteins [, , , ]. |
|
•
•
•
•
•
|
Publication |
First Author: |
Belin S |
Year: |
2019 |
Journal: |
Hum Mol Genet |
Title: |
Neuregulin 1 type III improves peripheral nerve myelination in a mouse model of congenital hypomyelinating neuropathy. |
Volume: |
28 |
Issue: |
8 |
Pages: |
1260-1273 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rr102/Rr102 |
Background: |
involves: C57BL/6 * DBA/2 |
Zygosity: |
hm |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Wilm's tumour (WT) is an embryonal malignancy of the kidney, affecting around 1 in 10,000 infants. It occurs in both sporadic and hereditary forms. Inactivation of WT1 is one of the causes of Wilm's tumour. Defects in the WT1 gene are also associated with Denys-Drash Syndrome (DDS), which is characterised by typical nephropathy and genital abnormalities. The WT1 gene product shows similarity to the zinc fingers of the mammalian growth regulated EGR1 and EGR2 proteins [, , , ].This entry represents a Wilm's tumour protein. |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion D, John Svaren |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion, John Svaren |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion E, John Svaren |
Allele Type: |
Transgenic |
Attribute String: |
Reporter |
|
•
•
•
•
•
|
Publication |
First Author: |
Buckler AJ |
Year: |
1991 |
Journal: |
Mol Cell Biol |
Title: |
Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. |
Volume: |
11 |
Issue: |
3 |
Pages: |
1707-12 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rauscher FJ 3rd |
Year: |
1993 |
Journal: |
FASEB J |
Title: |
The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. |
Volume: |
7 |
Issue: |
10 |
Pages: |
896-903 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gessler M |
Year: |
1990 |
Journal: |
Nature |
Title: |
Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. |
Volume: |
343 |
Issue: |
6260 |
Pages: |
774-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Little MH |
Year: |
1992 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Zinc finger point mutations within the WT1 gene in Wilms tumor patients. |
Volume: |
89 |
Issue: |
11 |
Pages: |
4791-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Jiang Y |
Year: |
2014 |
Journal: |
Cancer Discov |
Title: |
Tracing the roots of cancer evolution. |
Volume: |
4 |
Issue: |
9 |
Pages: |
995-7 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rr102/Rr102<+> Rr111/Rr111<+> |
Background: |
involves: C57BL/6 * DBA/2 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Rengarajan J |
Year: |
2000 |
Journal: |
Immunity |
Title: |
Sequential involvement of NFAT and Egr transcription factors in FasL regulation. |
Volume: |
12 |
Issue: |
3 |
Pages: |
293-300 |
|
•
•
•
•
•
|
Publication |
First Author: |
Patwardhan S |
Year: |
1991 |
Journal: |
Oncogene |
Title: |
EGR3, a novel member of the Egr family of genes encoding immediate-early transcription factors. |
Volume: |
6 |
Issue: |
6 |
Pages: |
917-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
He Y |
Year: |
2010 |
Journal: |
Nat Neurosci |
Title: |
Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. |
Volume: |
13 |
Issue: |
12 |
Pages: |
1472-80 |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE14242 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Publication |
First Author: |
Tourtellotte WG |
Year: |
1998 |
Journal: |
Nat Genet |
Title: |
Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. |
Volume: |
20 |
Issue: |
1 |
Pages: |
87-91 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bedel R |
Year: |
2014 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Effective functional maturation of invariant natural killer T cells is constrained by negative selection and T-cell antigen receptor affinity. |
Volume: |
111 |
Issue: |
1 |
Pages: |
E119-28 |
|
•
•
•
•
•
|
Publication |
First Author: |
Liu S |
Year: |
2009 |
Journal: |
Mol Endocrinol |
Title: |
Novel regulators of Fgf23 expression and mineralization in Hyp bone. |
Volume: |
23 |
Issue: |
9 |
Pages: |
1505-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hong J |
Year: |
2024 |
Journal: |
Glia |
Title: |
PMP2 regulates myelin thickening and ATP production during remyelination. |
Volume: |
72 |
Issue: |
5 |
Pages: |
885-898 |
|
•
•
•
•
•
|
Publication |
First Author: |
Märklin M |
Year: |
2017 |
Journal: |
Nat Commun |
Title: |
NFAT2 is a critical regulator of the anergic phenotype in chronic lymphocytic leukaemia. |
Volume: |
8 |
Issue: |
1 |
Pages: |
755 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li C |
Year: |
2011 |
Journal: |
Neuroscience |
Title: |
Microarray analysis of gene expression changes in the brains of NR2B-induced memory-enhanced mice. |
Volume: |
197 |
|
Pages: |
121-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tourtellotte WG |
Year: |
2000 |
Journal: |
Mol Cell Biol |
Title: |
Functional compensation by Egr4 in Egr1-dependent luteinizing hormone regulation and Leydig cell steroidogenesis. |
Volume: |
20 |
Issue: |
14 |
Pages: |
5261-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu Q |
Year: |
2022 |
Journal: |
Diabetes |
Title: |
Obesity-Induced miR-455 Upregulation Promotes Adaptive Pancreatic β-Cell Proliferation Through the CPEB1/CDKN1B Pathway. |
Volume: |
71 |
Issue: |
3 |
Pages: |
394-411 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hastings KT |
Year: |
2017 |
Journal: |
Mol Immunol |
Title: |
Nab2 maintains thymus cellularity with aging and stress. |
Volume: |
85 |
|
Pages: |
185-195 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hung H |
Year: |
2012 |
Journal: |
J Neurosci |
Title: |
The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination. |
Volume: |
32 |
Issue: |
5 |
Pages: |
1517-27 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tang Y |
Year: |
2015 |
Journal: |
Cardiovasc Res |
Title: |
MicroRNA-150 protects the mouse heart from ischaemic injury by regulating cell death. |
Volume: |
106 |
Issue: |
3 |
Pages: |
387-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
Torres OV |
Year: |
2015 |
Journal: |
Sci Rep |
Title: |
CAMKII-conditional deletion of histone deacetylase 2 potentiates acute methamphetamine-induced expression of immediate early genes in the mouse nucleus accumbens. |
Volume: |
5 |
|
Pages: |
13396 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ryu EJ |
Year: |
2007 |
Journal: |
J Neurosci |
Title: |
Misexpression of Pou3f1 results in peripheral nerve hypomyelination and axonal loss. |
Volume: |
27 |
Issue: |
43 |
Pages: |
11552-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Benturquia N |
Year: |
2008 |
Journal: |
Brain Res |
Title: |
Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice. |
Volume: |
1211 |
|
Pages: |
1-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shieh JT |
Year: |
2011 |
Journal: |
PLoS One |
Title: |
Elevated miR-499 levels blunt the cardiac stress response. |
Volume: |
6 |
Issue: |
5 |
Pages: |
e19481 |
|
•
•
•
•
•
|
Publication |
First Author: |
Salotti J |
Year: |
2015 |
Journal: |
Mol Cell Biol |
Title: |
An Arf-Egr-C/EBPβ pathway linked to ras-induced senescence and cancer. |
Volume: |
35 |
Issue: |
5 |
Pages: |
866-83 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sun JJ |
Year: |
2017 |
Journal: |
Sci Rep |
Title: |
Embryonic hindbrain patterning genes delineate distinct cardio-respiratory and metabolic homeostatic populations in the adult. |
Volume: |
7 |
Issue: |
1 |
Pages: |
9117 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhang X |
Year: |
2020 |
Journal: |
Cell Mol Immunol |
Title: |
TRAF3IP3 at the trans-Golgi network regulates NKT2 maturation via the MEK/ERK signaling pathway. |
Volume: |
17 |
Issue: |
4 |
Pages: |
395-406 |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
449
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
305
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
288
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
406
|
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
360
|
Fragment?: |
true |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
517
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
302
|
Fragment?: |
false |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
406
|
Fragment?: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Calella AM |
Year: |
2007 |
Journal: |
Neural Dev |
Title: |
Neurotrophin/Trk receptor signaling mediates C/EBPalpha, -beta and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription. |
Volume: |
2 |
|
Pages: |
4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Desouza LA |
Year: |
2021 |
Journal: |
Front Mol Neurosci |
Title: |
The Hallucinogenic Serotonin2A Receptor Agonist, 2,5-Dimethoxy-4-Iodoamphetamine, Promotes cAMP Response Element Binding Protein-Dependent Gene Expression of Specific Plasticity-Associated Genes in the Rodent Neocortex. |
Volume: |
14 |
|
Pages: |
790213 |
|
•
•
•
•
•
|
Publication |
First Author: |
Mu C |
Year: |
2017 |
Journal: |
J Leukoc Biol |
Title: |
Enhanced suppression of polyclonal CD8+25+ regulatory T cells via exosomal arming of antigen-specific peptide/MHC complexes. |
Volume: |
101 |
Issue: |
5 |
Pages: |
1221-1231 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rondahl V |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Lrig2-deficient mice are protected against PDGFB-induced glioma. |
Volume: |
8 |
Issue: |
9 |
Pages: |
e73635 |
|
•
•
•
•
•
|
Publication |
First Author: |
Fujikawa Y |
Year: |
2024 |
Journal: |
Front Immunol |
Title: |
Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice. |
Volume: |
15 |
|
Pages: |
1168323 |
|
•
•
•
•
•
|
Publication |
First Author: |
European Mouse Mutant Archive |
Year: |
2003 |
Journal: |
Unpublished |
Title: |
Information obtained from the European Mouse Mutant Archive (EMMA) |
|
|
|
|
•
•
•
•
•
|
Publication |
First Author: |
Gerhard DS |
Year: |
2004 |
Journal: |
Genome Res |
Title: |
The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). |
Volume: |
14 |
Issue: |
10B |
Pages: |
2121-7 |
|
•
•
•
•
•
|
Publication |
First Author: |
Church DM |
Year: |
2009 |
Journal: |
PLoS Biol |
Title: |
Lineage-specific biology revealed by a finished genome assembly of the mouse. |
Volume: |
7 |
Issue: |
5 |
Pages: |
e1000112 |
|
•
•
•
•
•
|